GOLIMUMAB

golimumab 50 mg/0.5 mL injection, 0.5 mL syringe

GOLIMUMAB (3428K)

golimumab 50 mg/0.5 mL injection, 0.5 mL syringe
3428K
Body System:
Manner of administration:Injection
General Schedule
Authority Required

Restriction

Indication: Severe active rheumatoid arthritis
Treatment phase: First continuing treatment

Restriction

Indication: Severe active rheumatoid arthritis
Treatment phase: First continuing treatment - balance of supply
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 5 DPMQ: $1,052.63 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Simponi